[Announcements] To commence a period of public comments for drafting "Fee-charging Standards of Review for the Registration of Orphan Drugs"

[Announcements] Revise the relevant certification documents for the simplified process of applying for the review of clinical trials of new drugs

[Announcements] Adverse Drug Reaction Report Forms and Completion Guidelines

[Announcements] Amendment on partial articles of "Regulations for Good Clinical Practice"

[Announcements] Charge Standards of Review Fees for the Registration of Western Medicines

[Announcements] Amendment on Article 21 of "Regulations of Bioavailability and Bioequivalence Studies"

[Announcements] Revised the application and review criteria for clinical trials of human cell therapeutics

[Announcements] Recommendations and principles for the implementation of drug clinical trials during the prevention of severe and special infectious pneumonia

[Announcements] Amendment on Article 21 of "Regulations of Bioavailability and Bioequivalence Studies"